
Wednesday, July 20, 2022 10:18:32 AM
BONNOJULY 19, 2022
CANNABIS CANADAFEATUREDLAWMARIJUANA NEWSPOLITICSSCIENCE0COMMENTS62019VIEWS
Poor cultivation practices led to the mandatory testing of cannabis during Canada’s medical era. More than one cultivator was at fault for incidents involving banned pesticides, though. And in 2019, one of the guilty producers led to more mandatory tests and new licenses after a different violation.
Mandatory tests for license holders
A report on the issue discussed new testing policies designed to mitigate and prevent more major contamination events. Beyond testing facilities, a new license system launches next month. Rather than pesticides, Organigram operated cooling towers without an adequate cleaning system. Bacteria built up inside the system and blew across Moncton, New Brunswick. An outcry ensued over the lack of mandatory rules after the incident since more than a dozen individuals fell seriously ill.
Tests are one step toward containing future outbreaks. But Bill 91 includes a guideline for the new registry of cooling tower licenses after Organigram’s violation. And according to a press release by New Brunswick’s Ministry of Health, licenses to operate cooling towers will be mandatory beginning August 1, 2022. But the annual $450 fee was waived until March 31, 2023
Dorothy Shephard mandated a cooling tower license in response to Organigram's violation that caused a Legionairre's outbreak.
Swapping ministers
Bill 91 governs the new license system for cooling towers, proposed by former Minister of Health — Dorothy Shephard. But shortly after the bill passed, Shephard was swapped with the Minister of Social Development, Bruce Fitch. The reason for this, though, was an unfortunate death in a waiting room in a hospital’s emergency ward.
Earlier on June 30, however, Premier Higgins announced New Brunswick’s new Deputy Health Minister. And shortly after the law passed, Organigram settled an older class action suit.

Liked By
Spread the love. Be the first to like this post!
Recent OGI News
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 01/26/2023 04:18:49 PM
- Organigram Provides NASDAQ Listing Update • Business Wire • 01/26/2023 11:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 01/12/2023 12:47:58 PM
- Organigram Reports Record First Quarter Fiscal 2023 Results • Business Wire • 01/12/2023 11:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 01/05/2023 02:53:51 PM
- Organigram to Report First Quarter Fiscal 2023 Results on January 12, 2023 • Business Wire • 01/05/2023 11:00:00 AM
- Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl) • Edgar (US Regulatory) • 12/19/2022 04:25:43 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/09/2022 02:54:27 PM
- Organigram Wins KIND Magazine’s Cannabis Company of the Year Award and Most Innovative Product of the Year for Edison JOLTS • Business Wire • 12/08/2022 11:00:00 AM
- Three Reasons It’s Time To Get Bullish On Organigram • ValueWalk • 11/29/2022 11:51:33 PM
- Organigram Reports Record Fourth Quarter and Full Year Fiscal 2022 Results • Business Wire • 11/29/2022 01:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/23/2022 06:28:57 PM
- Organigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash Categories • Business Wire • 11/23/2022 11:00:00 AM
- High Tide Becomes Top Revenue-Generating Cannabis Company in Canada • PR Newswire (US) • 11/22/2022 11:00:00 AM
- High Tide Becomes Top Revenue-Generating Cannabis Company in Canada • PR Newswire (Canada) • 11/22/2022 11:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/18/2022 01:22:51 PM
- Organigram to Report Annual Fiscal 2022 Results on November 28, 2022 • Business Wire • 11/18/2022 01:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/17/2022 06:45:02 PM
- Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies • GlobeNewswire Inc. • 11/17/2022 01:17:09 PM
- Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies • Business Wire • 11/17/2022 01:00:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 07/14/2022 04:23:01 PM
- Organigram Reports Third Quarter Fiscal 2022 Results • Business Wire • 07/14/2022 10:00:00 AM
- Organigram to Report Third Quarter 2022 Results on July 14, 2022 • Business Wire • 07/09/2022 12:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 06/24/2022 05:42:09 PM
- Proposed Settlement Reached in 2016 Class Action • Business Wire • 06/24/2022 12:00:00 AM
1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • CBDW • Jan 27, 2023 11:59 AM
IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM
Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM
UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM
Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM
B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM